Interoperability of RTN1A in dendrite dynamics and immune functions in human Langerhans cells
- Department of Dermatology, Medical University of Vienna, Austria
- Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Austria
- Department of Plastic and Reconstructive Surgery, Medical University of Vienna, Austria
Figures
Figure 1 with 1 supplement
Impairment of Reticulon 1A (RTN1A) functionality instigates a roundish morphology in resident Langerhans cells (rLCs).
(A) Experimental workflow demonstrating the cultivation of human epidermal sheets with an α-RTN1A antibody (ab) and the isotype for indicated time points and subsequent analysis strategies. (B–C) Representative immunofluorescence (IF) images of isotype- and α-RTN1A-treated epidermal sheets at indicated time points stained for CD207 (green), a secondary ab (red) to visualize the uptake of the isotype and α-RTN1A ab by rLCs and nuclear counterstaining with 4′,6-diamidino-2-phenylindole (DAPI) (blue). Zoom-ins of the boxed areas are also shown as 3D projections underneath. RTN1A+ rLCs: yellow arrows, RTN1A- rLCs: white arrows. n=3, scale bar: 20 μm. (D) Representative IF images showing RTN1A, CD207, vimentin, and DAPI staining in untreated (UT), isotype- and α-RTN1A-treated human epidermal sheets after 24 hr of cultivation. Co-localization of RTN1A with vimentin: pinkish arrows, rLCs with partially retracted dendrites: white arrows. n=4, scale bar: 20 μm. (E, F) Enumeration, percentage, and distribution of dendritic and roundish rLCs in epidermal sheets upon 24 hr of culture and indicated treatment. (E) Data are shown as standard error of the mean (SEM) from four fields of view (FOVs) of four donors and were analyzed using two-way ANOVA with Tukey’s multiple-comparison test. (F) Data represent mean of four donors. *p≤0.05, **p≤0.01.
Figure 1—figure supplement 1
The frequency of RTN1A protein expression in resident Langerhans cells (rLCs) and emigrated LCs (eLCs).
(A.) Percentage of total Reticulon 1A+ (RTN1A+) resident Langerhans cells (rLCs) and emigrated LCs (eLCs), analyzed with flow cytometry. Viable rLCs and eLCs were gated for CD1a and CD207. Data shown as standard error of the mean (SEM), each dot represents one donor. rLCs: n=4, eLCs = n = 5. (B, C) Frequency of RTN1A expression in LCs. Representative dot blots showing flow cytometry analysis of (B) freshly isolated rLCs and (C) eLCs, stained for CD207, CD1a, and RTN1A. Quantification of the percentage of double-positive LCs s shown. Data shown as standard error of the mean (SEM), each dot represents one donor. CD207: n=2–4, CD1a: n=5.
Figure 2
Inhibition of Reticulon 1A (RTN1A) in resident Langerhans cells (rLCs) significantly alters dendrite length and distribution.
(A) 3D projections of epidermal sheets upon 24 hr of culture, indicated treatment, and vimentin (VIM) staining (left panel). Shown are single rLC 3D trajectories based on intermediate filament expression (right panel). Scale bar: 10 μm. (B, C) Evaluation of the average rLC branch lengths and Sholl analysis of rLC dendricity upon 24 hr of culture and indicated treatments. Four fields of view (FOVs) were evaluated of four donors and data analyzed using two-way ANOVA with Tukey‘s multiple-comparison test, ns = not significant. *p≤0.05, ****p≤0.0001.
Figure 3
Hampering Reticulon 1A (RTN1A) function decreases the Langerhans cell (LC) migration potential and alters the marker expression in emigrated LCs (eLCs).
(A, B) Enumeration and ab uptake of pre-gated CD207+CD1a+ eLCs, collected from culture wells with epidermal sheets at indicated time points and analyzed via flow cytometry. (A) Data are presented as standard error of the mean (SEM) from triplicates of three donors. Ordinary one-way ANOVA with Tukey’s multi-comparison test was used. *p≤0.05. (B) Data from triplicates, including three donors, are shown as mean fold change to untreated (UT) eLCs. (C) Marker expression profile of pre-gated CD207+ eLCs upon 24 hr of culture, treatment, and flow cytometry analysis. Data shown represent mean ± SEM of three donors and were analyzed using two-way ANOVA Tukey’s multi-comparison test. *p≤0.05. (D) Adhesion molecule concentrations in supernatants of cultivated epidermal sheets with indicated 24 hr treatments and subsequent LEGENDplex bead array measurement. Data are shown as SEM from duplicates of four donors and were analyzed using two-way ANOVA with Tukey’s multiple-comparison test. *p≤0.05, **p≤0.01.
Figure 4 with 1 supplement
Expression of Reticulon 1A (RTN1A) in the myeloid THP-1 cell line affects the cell size.
(A) Workflow for the generation of THP-1 RTN1A+ cells and their comparative analysis with THP-1 wild-type (wt) cells. (B) Representative immunofluorescence (IF) images of THP-1 wt and THP-1 RTN1A+ cells on adhesion slides stained for RTN1A, vimentin (VIM), and nuclei (4′,6-diamidino-2-phenylindole [DAPI]). n=4; scale bar: 10 μm. (C) Comparative evaluation of the cell area revealed substantial divergences between THP-1 wt and THP-1 RTN1A+ cells. Data are shown as standard error of the mean (SEM) from four fields of view (FOVs; n=4) and were analyzed using unpaired, two-tailed Student’s t test. ****p≤0.0001. (D, E) Representative IF images and quantification using Manders’ coefficient of RTN1A co-localization with filamentous proteins in a THP-1 RTN1A+ cell within three-cell compartments: bottom, middle, and top of the cell (right panel). Scale bar: 10 μm. Data are shown as SEM (10 cells/4 FOVs; n=2), and analyzed using two-way ANOVA with Tukey‘s multiple-comparison test. *p≤0.05, ****p≤0.0001. (F) Evaluation of the cell number and proliferation rate of THP-1 wt and THP-1 RTN1A+ cells within the time period indicated. Data presented as SEM were analyzed with two-way ANOVA, Sidak’s multiple-comparison test (n=3). *p<0.05, **p≤0.01, ***p≤0.001.
Figure 4—figure supplement 1
Expression of RTN1A in THP-1 cells leads to constriction of intermediate filaments and their colocalization with RTN1A.
(A) Representative immunofluorescence (IF) images of THP-1 wild-type (wt) and THP-1 Reticulon 1A+ (RTN1A+) cells on adhesion slides stained with vimentin (VIM) and demonstrated as LUT-fire. THP-1 RTN1A+ cells display markedly more condensed intermediate filament structures in comparison to THP-1 wt cells. Scale bar: 10 μm. (B) Representative IF image of THP-1 RTN1A+ cells stained for RTN1A, F-actin, VIM, and nuclei. Image is shown as montage of Z-stack slices.
Figure 5 with 1 supplement
Reticulon 1A (RTN1A) considerably alters the morphology of THP-1 RTN1A+ macrophages (Mφs) as well as enhances aggregate formation and impairs Ca2+ flux in THP-1 RTN1A+ cells.
(A) Workflow for the differentiation and comparative analysis of THP-1 RTN1A+ Mφs and THP-1 wild-type (wt) Mφs. (B) Representative bright-field (BF) and immunofluorescence images (IF; co-staining with RTN1A, F-actin, vimentin [VIM], and 4′,6-diamidino-2-phenylindole [DAPI]) of THP-1 wt Mφs and THP-1 RTN1A+ Mφs. Scale bar: BF: 31 and IF: 10 μm, n=4. (C, D) Comparative analysis of cell body size and average length of cell protrusions of differentiated THP-1 wt Mφs and THP-1 RTN1A+ Mφs. Data were analyzed using unpaired, two-tailed Student’s t test, n=4. ****p≤0.0001. (E) Comparative co-localization between RTN1A, F-actin, and VIM using Manders’ coefficient. Data shown are standard error of the mean (SEM), n=4. ****p≤0.0001. (F) Representative BF image of THP-1 wt and THP-1 RTN1A+ cells forming aggregates during culture. Scale bar: 100 µm. (G) Enumeration of THP-1 wt and THP-1 RTN1A+ cell aggregates. Data are demonstrated as SEM from four fields of view per passage and analyzed using unpaired, two-tailed Student’s t test, n=6. (H) Adhesion molecule concentrations in supernatants after 48 hr of THP-1 wt and THP-1 RTN1A+ cell cultivation, measured in duplicates with LEGENDplex bead array. Data are shown as SEM from three different passages and were analyzed using unpaired, two-tailed Student’s t test. *p≤0.05. (I, J) Ratiomeric analysis of early and late phase calcium flux in THP-1 wt and THP-1 RTN1A+ cells using Fura-3 calcium indicator, ionomycin (n=5), and thapsigargin (n=4). Unpaired two-tailed t test was used for the response to both ionomycin and thapsigargin. ****p≤0.0001.
Figure 5—figure supplement 1
Enumeration of small and big THP-1 wild-type (wt) and THP-1 Reticulon 1A+ (RTN1A+) cell aggregates per 0.7 mm2 from four fields of view (FOVs).
The size of cellular aggregates was defined based on their area (small ~312.5 µm2 and big ~637.6 µm2). n=6.
Figure 6 with 1 supplement
Emigrated LCs (eLCs) significantly decrease Reticulon 1A (RTN1A) expression upon stimulation with TLR1/2, TLR2, and TLR7 agonists.
(A) Graphical presentation for the stimulation of epidermal sheets with TLR agonists and analysis. (B) Representative FACS blots of RTN1A expression in pre-gated eLCs upon stimulation of epidermal sheets with TLR1/2 (Pam3CSK4), TLR2 (Listeria monocytogenes), TLR2/6 (mycoplasma salivarium), TLR7 (imiquimod), TLR3/7 [polyadenylic:polyuridylic acid (poly(A:U))], and TLR3 [low and high molecular weight polyinosinic:polycytidylic acid (LMW and HMW poly(I:C))] for 24 hr. (C, D) The percentage and geometric mean fluorescence intensity (gMFI) of RTN1A in eLCs are shown as standard error of the mean (SEM) of triplicates, and analyzed using two-way ANOVA with Tukey‘s multiple-comparison test. *p≤0.05, **p≤0.01, ***p≤0.001. Some p values were not significant (ns), yet indicative of a trend for the reduction of RTN1A expression intensity. (E) Recovery of the RTN1A protein expression (% of RTN1A+ eLCs) after 48 hr of cultivation with indicated TLR agonists. Data shown represent mean ± SEM of triplicates from three donors.
Figure 6—figure supplement 1
Expression pattern of RTN1A protein within TLR-activated eLCs and their quantification.
(A) Gating strategy for emigrated Langerhans cells (eLCs) as analyzed with flow cytometry. (B, C) Reticulon 1A (RTN1A) distribution within TLR-activated eLCs and their quantification. Data shown represent mean ± standard error of the mean (SEM) of triplicates from four donors. Data set was analyzed using two-way ANOVA, Dunnett’s multiple-comparison test. *p≤0.05.
Figure 7 with 1 supplement
Stimulation of epidermal sheets with TLR1/2, TLR2, and TLR7 agonists initiates cluster formation of resident Langerhans cells (rLCs).
(A) Representative immunofluorescence (IF) images of untreated (control) and indicated TLR-treated epidermal sheets upon 24 hr of culture stained with Reticulon 1A (RTN1A) (red), CD83, CD86 (green), and 4′,6-diamidino-2-phenylindole (DAPI) (blue). n=5, scale bar: 20 μm. (B) 3D projection of rLCs in an epidermal sheet after incubation with a TLR7 agonist for 24 hr (A). rLCs form big (arrow) and small (asterisk) clusters yet were also visible as single activated dendritic rLCs (hashtag). (C, D) Expression intensity of indicated markers in rLCs upon culture and treatment. Data are shown as standard error of the mean (SEM) representing four fields of view of five donors, analyzed with two-way ANOVA Tukey’s multiple-comparison test. *p≤0.05,***p≤0.001. (E) Representative IF images of untreated (control) and TLR-stimulated epidermal sheets stained for MMP-9, CCR-7, and 4′,6-diamidino-2-phenylindole (DAPI). n=2, scale bar: 20 μm. (F) Inflammatory cyto- and chemokine concentrations in supernatants of epidermal sheet cultures after 24 hr, measured in duplicates with LEGENDplex bead array. Data are shown as SEM of four donors and analyzed using two-way ANOVA with Durrett’s multiple-comparison test. *p≤0.05, **p≤0.01.
Figure 7—figure supplement 1
Resident Langerhans cells (rLCs) do not proliferate in clusters upon TLR stimulation and produce elevated levels of IL-10 and IL-23.
(A) Representative immunofluorescence images of epidermal sheets after 24 hr of cultivation only or treatment with TLR 1/2, and TLR7 agonists. Epidermal sheets were stained for Ki67 (green) and nuclei (blue). n=2, scale bar: 20 μm. (B,C) Inflammatory cyto- and chemokines concentration measured in supernatants of epidermal sheet cultures after 24 hr, with LEGENDplex bead array. Data are shown as SEM from four donors and analyzed using two-way ANOVA with Durrett’s multiple-comparison test and were not significant.
Figure 8
Summary and overview on the function of Reticulon 1A (RTN1A).
Inhibition of RTN1A protein in resident Langerhans cells (LCs) in human epidermis ex vivo caused dendrite retraction, induced cell adhesion, and reduced LC migration. Stimulation of LCs with TLR agonists downregulated RTN1A expression and induced cluster formation (upper panel). Furthermore, expression of RTN1A in THP-1 cells altered cell size, morphology, calcium release from endoplasmic reticulum (ER) stores and cell aggregation in vitro (lower panel).
Author response image 1
Tables
Key resources table
| Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
|---|---|---|---|---|
| Gene (Homo sapiens) | RTN1A | NM_0211369, Eurofins (this paper) | ||
| Cell line (Homo sapiens) | THP-1 | ATCC | TIB-202 | |
| Transfected construct (Homo sapiens) | pHR‐SIN‐BX‐IRES‐Emerald | Paster et al., 2013 | Lentiviral construct to transfect the THP-1 cell line and express RTN1A | |
| Antibody | α-RTN1A (clone: mon162), unconjugated (Mouse monoclonal) | abcam | ab9274 | IF staining – 0.2 µg/ml; cultivation of epidermal sheets – 5 µg/ml/ |
| Antibody | α-RTN1A (clone: mon162), unconjugated (Mouse monoclonal) | Novus Biologicals, Biotechne | NBP1-97677 | IF staining – 0.2 µg/ml; cultivation of epidermal sheets – 5 µg/ml/ |
| Antibody | α-RTN1A-APC (clone: mon161, Mouse monoclonal) | Novus Biologicals, Biotechne | NBP1-97678AF647 | FACS analysis – 1:500 |
| Antibody | IgG1 [15-6E10A7] - Isotype control, unconjugated (Mouse monoclonal) | abcam | ab170190 | IF staining – 0.2 µg/ml; cultivation of epidermal sheets – 5 µg/ml/ |
| Antibody | α-CD207-FITC (clone 929F3.01, Rat monoclonal) | Dendritics | Cat:DDX0362 | IF staining – 0.25 µg/ml. 1:250 |
| Antibody | α-CD207, unconjugated (Rabbit monoclonal) | Sigma-Aldrich | HPA011216 | IF staining – 1:200 |
| Antibody | α-Human CD207- PE (clone DCGM4, Mouse) | Beckman Coulter | PN IM3577 | FACS analysis – 1:200 |
| Antibody | α-Human HLA- DR-PE (Mouse) | BD Pharmingen | Cat. 347401 | FACS analysis – 1:100 |
| Antibody | α-Human CD1a- PE (Mouse) | BD Pharmingen | Cat. 555807 | FACS analysis – 1:100 |
| Antibody | α-Human CD83- FITC (Mouse) | BD Pharmingen | Cat. 556910 | FACS analysis, IF staining – 1:100 |
| Antibody | α-Human CD86- FITC (Mouse) | BD Pharmingen | Cat. 555657 | FACS analysis, IF staining – 1:100 |
| Antibody | α-CCR7-APC | Miltenyi Biotech | 5171113456 | FACS analysis, IF staining – 1:100 |
| Antibody | Recombinant α- Vimentin-FITC (clone REA409) | Miltenyi Biotec | 130-116-508 | IF staining – 1:50 |
| Antibody | Recombinant FITC isotype control | Miltenyi Biotech | 130-113-449 | IF staining – 1:50 |
| Antibody | F(ab')2-Goat anti- Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 488 | Life Technologies | REF A-11070 | IF staining – 1:500 |
| Antibody | F(ab')2-Goat anti- Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 546 | Invitrogen, Thermo Fisher Scientific | REF A-11018 | IF staining – 1:500 |
| Antibody | Alexa Flour 647F(ab´) 2 fragment of goat α-rabbit IgG (H+L) | Invitrogen, Thermo Fisher Scientific | REF A-21246 | IF staining – 1:500 |
| Commercial assay or kit | Human TLR kit | InvitroGen | Cat. tlrl-kit1hw | |
| Commercial assay or kit | LEGENDplex Human inflammatory Panel 1 (13-plex) w/VbP | Biolegend | Cat. 740809 | |
| Commercial assay or kit | LEGENDplex Human Adhesion Molecule Panel (13-plex) w/VbP | Biolegend | Cat. 740946 | |
| Chemical compound, drug | Thapsigargin | Invitrogen, Thermo Fisher Scientific | T7458 | |
| Software, algorithm | GraphPad Prism v8.0.1 | GraphPad Software | ||
| Software, algorithm | FlowJo v10.6.1 | BD (Becton, Dickinson & Company) | ||
| Software, algorithm | Fiji: ImageJ | Schindelin et al., 2012 | ||
| Software, algorithm | ImarisViewer 9.8 | Oxford Instruments | ||
| Software, algorithm | Adobe Illustrator CS7 | Adobe Inc | ||
| Other | Alexa Fluor 647 Phalloidin | Invitrogen | REF A-22287 | IF staining – 1:500 |
| Other | Fixable Viability Dye eFluor 450 | eBioscience | Cat. 65-0863-18 | FACS analysis – 1:1000 |
| Other | DAPI (4′,6-diamidino- 2-phenylindole dihydrochloride) | Sigma-Aldrich | Cat. D9542 | IF staining – 1:5000 |
| Other | Dispase II (neutral protease, grade II) | Roche Diagnostics | 04942078001 | 1.2 U/ml |
| Other | ProLong Gold antifade reagent | InvitroGen | Cat. P36934 | |
| Other | IC Fixation Buffer | eBioscience | Cat. 00-8222-49 | |
| Other | Permeabilization Buffer (×10) | eBioscience | Cat. 00-8333-56 | |
| Other | Phorbol 12-myristate 13-acetate (PMA), PKC activator | Abcam | Ab120297 | |
| Other | Triton X-100 | Sigma-Aldrich | T9284 | |
| Other | Fura Red, AM, cell permeant | Invitrogen, Thermo Fisher Scientific | F3020 | |
| Other | CellTrace CFSE Cell Proliferation Kit, for flow cytometry | Invitrogen, Thermo Fisher Scientific | C34554 | |
| Other | Ionomycin- Calcium ionophore – NFAT Activator | InvivoGen | inh-ion | |
| Other | Fibronectin Solution Human | PromoCell | Cat. C-43060 |
Additional files
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Interoperability of RTN1A in dendrite dynamics and immune functions in human Langerhans cells
eLife 11:e80578.
https://doi.org/10.7554/eLife.80578
